Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Łos, Marek J  [Clear All Filters]
2015
Jain MVilas, Jamgamreddy JR, Grabarek J, Schweizer F, Klonisch T, Cieślar-Pobuda A, Łos MJ. Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1). Cell Cycle. 2015.
2016
Likus W, Siemianowicz K, Bieńk K, Pakuła M, Pathak H, Dutta C, Wang Q, Shojaei S, Assaraf YG, Ghavami S, et al. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?. Drug Resist Updat. 2016;25:13-25.
2019
Sharifzad F, Ghavami S, Mardpour S, Mollapour M, Azizi Z, Taghikhani A, Łos MJ, Verdi J, Fakharian E, Ebrahimi M, et al. Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resist Updat. 2019;42:35-45.
2020
Hybiak J, Jankowska K, Machaj F, Rosik J, Broniarek I, Żyluk A, Hilderman GC, Małecki A, Łos MJ, Urasińska E. Invited contribution to the volume: "Stem cells & cancer stem cells, regenerative medicine & cancer" (VSI stem cells) reprogramming and transdifferentiation - two key processes for regenerative medicine. Eur J Pharmacol. 2020:173202.
Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad REslami, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SMahmoud, Łos MJ, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol. 2020:173263.
2022
Seyed-Khorrami S-M, Soleimanjahi H, Łos MJ, Zandi K, Emameh RZolfaghari. Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers. Eur J Pharmacol. 2022:175393.
2023
Siapoush S, Rezaei R, Alavifard H, Hatami B, Zali MReza, Vosough M, Lorzadeh S, Łos MJ, Baghaei K, Ghavami S. Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis. Life Sci. 2023:121894.